Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium dobesilate for early diabetic kidney disease with non-proliferative diabetic retinopathy
ChiCTR1900025931Phase 4Not yet recruiting
- Sponsor
- The Second Department of Gerontology, The First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of calcium dobesilate in diabetic glomerulosclerosis (2 arms), sponsored by The Second Department of Gerontology, The First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: 24-hour urine albumin. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
calcium dobesilate
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR1900025931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025931.